Generate Biomedicines Inc stock is traded at $12.57, with a volume of 1,298,639. It is down -11.23% in the last 24 hours and down -9.63% over the past month. Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Previous Close:
$14.16
Open:
$14.00
24h Volume:
1,298,639
Relative Volume:
1.11
Market Cap:
$1.61B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-$2.16
Net Cash Flow:
-
1W Performance:
-20.29%
1M Performance:
-9.63%
6M Performance:
-18.48%
1Y Performance:
0.00%
1-Day Range:
$12.46$14.11
1-Week Range:
$12.46$14.64
52-Week Range:
$11.00$22.67
Generate Biomedicines Inc Stock (GENB) Company Profile
Name
Generate Biomedicines IncSector
HealthcareIndustry
BiotechnologyPhone
888-469-0055Address
101 SOUTH STREET, SUITE 900, SOMERVILLE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS